Video yรผkleniyor...

Video Yรผklenemedi

Ana Sayfaya Dรถn

๐๐ข๐จ๐•๐ž๐ง๐ญ๐ฎ๐ซ๐ž ๐•๐จ๐ข๐‚๐ž๐ฌ: General Atlantic's Brett Zbar describes investing through the lens of private equity, and touches on key technology themes that interest him. Full video:

BiotechTV's profile picture

BiotechTV

11,082 subscribers

13,658 gรถrรผntรผleme โ€ข 6 ay รถnce โ€ขvia X (Twitter)

LIVE

Anya Rossiโ€ข Live Now

Private livecam show

0 Yorum

Yorum bulunmuyor

Orijinal gรถnderinin yorumlarฤฑ burada gรถrรผnecek

Benzer Videolar

๐๐ข๐จ๐•๐ž๐ง๐ญ๐ฎ๐ซ๐ž ๐•๐จ๐ข๐‚๐ž๐ฌ: An early investor in recent mega successes such as Revolution Medicines, Peloton, Blueprint Medicines, and Parabilis, Thilo Schroeder describes his investment philosophy and focus on precision oncology. Full video:
8:50

๐๐ข๐จ๐•๐ž๐ง๐ญ๐ฎ๐ซ๐ž ๐•๐จ๐ข๐‚๐ž๐ฌ: An early investor in recent mega successes such as Revolution Medicines, Peloton, Blueprint Medicines, and Parabilis, Thilo Schroeder describes his investment philosophy and focus on precision oncology. Full video:

BiotechTV

13,446 gรถrรผntรผleme โ€ข 1 ay รถnce

๐๐ข๐จ๐•๐ž๐ง๐ญ๐ฎ๐ซ๐ž ๐•๐จ๐ข๐‚๐ž๐ฌ: Curie.Bio's Alexis Borisy on his entrepreneurial journey including CombinatoRx, Foundation Medicine, EQRx and more. Full video:
5:46

๐๐ข๐จ๐•๐ž๐ง๐ญ๐ฎ๐ซ๐ž ๐•๐จ๐ข๐‚๐ž๐ฌ: Curie.Bio's Alexis Borisy on his entrepreneurial journey including CombinatoRx, Foundation Medicine, EQRx and more. Full video:

BiotechTV

11,974 gรถrรผntรผleme โ€ข 1 yฤฑl รถnce

๐…๐ซ๐จ๐ฆ ๐’๐ž๐จ๐ฎ๐ฅ: Daejeon based Orum Therapeutics is pioneering the field of degrader-antibody conjugates. Founder SJ Lee describes the science and gives us an overview of biotech in Korea. Full video:
4:12

๐…๐ซ๐จ๐ฆ ๐’๐ž๐จ๐ฎ๐ฅ: Daejeon based Orum Therapeutics is pioneering the field of degrader-antibody conjugates. Founder SJ Lee describes the science and gives us an overview of biotech in Korea. Full video:

BiotechTV

15,588 gรถrรผntรผleme โ€ข 1 yฤฑl รถnce

Heidegger telling a Buddhist monk that, for Americans and Europeans, development is understood through the lens of modern technology.
1:04

Heidegger telling a Buddhist monk that, for Americans and Europeans, development is understood through the lens of modern technology.

Guilherme Gomes Santos

13,817 gรถrรผntรผleme โ€ข 5 gรผn รถnce

๐’๐… ๐‡๐ž๐š๐ฅ๐ญ๐ก๐œ๐š๐ซ๐ž ๐–๐ž๐ž๐ค: Abivax CEO Marc de Garidel reflects on a breakout 2025 for obefazimod and key data that will read out this year. $ABVX Full video:
3:51

๐’๐… ๐‡๐ž๐š๐ฅ๐ญ๐ก๐œ๐š๐ซ๐ž ๐–๐ž๐ž๐ค: Abivax CEO Marc de Garidel reflects on a breakout 2025 for obefazimod and key data that will read out this year. $ABVX Full video:

BiotechTV

73,893 gรถrรผntรผleme โ€ข 7 ay รถnce

๐…๐ซ๐จ๐ฆ ๐๐˜๐’๐„: Mizuho Senior Analyst Graig Suvannavejh shares his take on biotech and companies he covers that are in the news with key catalysts. $TERN $CRVS $INSM $CRBP $AXSM $NMRA $EYPT $AMLX Full video:
4:48

๐…๐ซ๐จ๐ฆ ๐๐˜๐’๐„: Mizuho Senior Analyst Graig Suvannavejh shares his take on biotech and companies he covers that are in the news with key catalysts. $TERN $CRVS $INSM $CRBP $AXSM $NMRA $EYPT $AMLX Full video:

BiotechTV

17,128 gรถrรผntรผleme โ€ข 7 ay รถnce

How does the Republic Note plan to democratize access to investing in private equity through tokenization? Andrew Durgee, President of Republic, explains the background of this profit-sharing digital asset, launched on INX on Avalanche ๐Ÿ‘‡
1:45

How does the Republic Note plan to democratize access to investing in private equity through tokenization? Andrew Durgee, President of Republic, explains the background of this profit-sharing digital asset, launched on INX on Avalanche ๐Ÿ‘‡

Avalanche๐Ÿ”บ

30,662 gรถrรผntรผleme โ€ข 2 yฤฑl รถnce

๐€๐ง๐š๐ฅ๐ฒ๐ฌ๐ญ ๐“๐ก๐ฎ๐ซ๐ฌ๐๐š๐ฒ๐ฌ: Mizuho Senior Biotech Analyst Graig Suvannavejh shares his take on three key biotech trials that are scheduled to read out soon, and one that recently happened. $IDYA $EYPT $OCUL $PVLA $CRVS Full video:
3:27

๐€๐ง๐š๐ฅ๐ฒ๐ฌ๐ญ ๐“๐ก๐ฎ๐ซ๐ฌ๐๐š๐ฒ๐ฌ: Mizuho Senior Biotech Analyst Graig Suvannavejh shares his take on three key biotech trials that are scheduled to read out soon, and one that recently happened. $IDYA $EYPT $OCUL $PVLA $CRVS Full video:

BiotechTV

29,397 gรถrรผntรผleme โ€ข 5 ay รถnce

๐’๐… ๐‡๐ž๐š๐ฅ๐ญ๐ก๐œ๐š๐ซ๐ž ๐–๐ž๐ž๐ค: Sana Bio's CEO Steve Harr describes the science behind the company's cell therapy program that aims to be a cure for type 1 diabetes. $SANA Full video:
4:40

๐’๐… ๐‡๐ž๐š๐ฅ๐ญ๐ก๐œ๐š๐ซ๐ž ๐–๐ž๐ž๐ค: Sana Bio's CEO Steve Harr describes the science behind the company's cell therapy program that aims to be a cure for type 1 diabetes. $SANA Full video:

BiotechTV

19,210 gรถrรผntรผleme โ€ข 6 ay รถnce

๐‚๐จ๐ฆ๐ฉ๐š๐ง๐ฒ ๐๐ž๐ฐ๐ฌ: With three approved products and filings for more over the near term, Axsome Therapeutics's CEO describes the scale and reach this company is building in the CNS space. $AXSM Full video:
3:36

๐‚๐จ๐ฆ๐ฉ๐š๐ง๐ฒ ๐๐ž๐ฐ๐ฌ: With three approved products and filings for more over the near term, Axsome Therapeutics's CEO describes the scale and reach this company is building in the CNS space. $AXSM Full video:

BiotechTV

20,894 gรถrรผntรผleme โ€ข 1 yฤฑl รถnce

Banking has come a long wayโ€ฆ but how did we get here? Our latest documentary delves into the evolution of banking in Nigeria through the lens of Sterling Bank, showcasing the key shifts and innovations that have shaped its growth. Full video airs on Feb 27th. Stay tuned!
1:34

Banking has come a long wayโ€ฆ but how did we get here? Our latest documentary delves into the evolution of banking in Nigeria through the lens of Sterling Bank, showcasing the key shifts and innovations that have shaped its growth. Full video airs on Feb 27th. Stay tuned!

Founders Connect

15,665 gรถrรผntรผleme โ€ข 1 yฤฑl รถnce

In this weekโ€™s episode of The Bid #podcast, Jeff Shen, co-head of Systematic Equities at BlackRock, joins host Oscar Pulido to help us understand the current themes driving investment opportunities, how his team identifies and evaluates emerging themes and the role of technology in shaping the future of investing. Listen ๐ŸŽง to the full episode here:
0:52

In this weekโ€™s episode of The Bid #podcast, Jeff Shen, co-head of Systematic Equities at BlackRock, joins host Oscar Pulido to help us understand the current themes driving investment opportunities, how his team identifies and evaluates emerging themes and the role of technology in shaping the future of investing. Listen ๐ŸŽง to the full episode here:

BlackRock

17,555 gรถrรผntรผleme โ€ข 1 yฤฑl รถnce

Company News: Nobel laureate @CarolynBertozzi on the launch of Firefly Bio and the science of degrader antibody conjugates. Full video:
1:16

Company News: Nobel laureate @CarolynBertozzi on the launch of Firefly Bio and the science of degrader antibody conjugates. Full video:

BiotechTV

14,355 gรถrรผntรผleme โ€ข 2 yฤฑl รถnce

๐‚๐จ๐ฆ๐ฉ๐š๐ง๐ฒ ๐๐ž๐ฐ๐ฌ: Abivax CEO Marc de Garidel discusses freshly released maintenance part 2 results for obefazimod in UC and describes how he believes it builds on initial data announced earlier this month. $ABVX Watch the full video:
3:01

๐‚๐จ๐ฆ๐ฉ๐š๐ง๐ฒ ๐๐ž๐ฐ๐ฌ: Abivax CEO Marc de Garidel discusses freshly released maintenance part 2 results for obefazimod in UC and describes how he believes it builds on initial data announced earlier this month. $ABVX Watch the full video:

BiotechTV

22,305 gรถrรผntรผleme โ€ข 1 ay รถnce

Ecological rebuilding, Ethereal lore, and more! Oh, and Chowdar. Discover Kโ€™aresh through the lens of the WoW development team. Watch the full video:
0:29

Ecological rebuilding, Ethereal lore, and more! Oh, and Chowdar. Discover Kโ€™aresh through the lens of the WoW development team. Watch the full video:

World of Warcraft

46,127 gรถrรผntรผleme โ€ข 1 yฤฑl รถnce

๐…๐ซ๐จ๐ฆ ๐๐˜๐’๐„: Metsera Inc. CEO Whit Bernard shares an update on the company's obesity programs, and comments on the state of the field post ADA. $MTSR Full video:
6:06

๐…๐ซ๐จ๐ฆ ๐๐˜๐’๐„: Metsera Inc. CEO Whit Bernard shares an update on the company's obesity programs, and comments on the state of the field post ADA. $MTSR Full video:

BiotechTV

10,378 gรถrรผntรผleme โ€ข 1 yฤฑl รถnce

How is crypto shaping up this year? In this video, we unpack @Coinbase Venturesโ€™ latest outlook and the key themes that could define crypto in 2026. Watch the full video ๐Ÿ‘‰
0:30

How is crypto shaping up this year? In this video, we unpack @Coinbase Venturesโ€™ latest outlook and the key themes that could define crypto in 2026. Watch the full video ๐Ÿ‘‰

CoinGecko

10,100 gรถrรผntรผleme โ€ข 5 ay รถnce

Company News: Intellia Therapeutics's Chief Scientific Officer elaborates on the news that the company successfully redosed patients with a CRISPR-based and LNP delivered therapy. $NTLA Full video:
4:26

Company News: Intellia Therapeutics's Chief Scientific Officer elaborates on the news that the company successfully redosed patients with a CRISPR-based and LNP delivered therapy. $NTLA Full video:

BiotechTV

21,947 gรถrรผntรผleme โ€ข 2 yฤฑl รถnce

Our Global Head of Banks and Diversified Finance Research, Betsy Graseck, discusses the three key themes that emerged from the U.S. Financials Conference: banking regulation, interest rates, and AI-driven efficiency. Explore how these issues are shaping the industry:
0:34

Our Global Head of Banks and Diversified Finance Research, Betsy Graseck, discusses the three key themes that emerged from the U.S. Financials Conference: banking regulation, interest rates, and AI-driven efficiency. Explore how these issues are shaping the industry:

Morgan Stanley

25,433 gรถrรผntรผleme โ€ข 1 yฤฑl รถnce